The Federal Government needs to optimize revenue generation, scale down and redirect borrowings and implement effective project-based assessments in order to achieve the overall developmental goals of ...

Born in Leeds, Joe finished his Spanish degree in 2018 before becoming an English teacher to football (soccer) players and managers, as well as collaborating with various football media outlets in ...

Cell therapy company Link Cell Therapies is launching with $60 million and a mission to develop potent CAR-T therapies that go after a range of tumors while avoiding patients' healthy tissue. The ...

Friday night lights have always been an integral part of Garden State culture. From way up in Sussex County all the way down to Cape May, New Jersey has long been a hotbed for competitive and ...

When Oklo Inc., a nuclear power startup, applied in 2020 to operate its first reactor, the company rested largely on outsize ambition. Its MIT-educated co-founders, a married couple named Jacob and ...

RPG Cyberpunk 2 director says there'd be no point in giving players more time with Jackie in Cyberpunk 2077: 'It's like saying we should spend more time on Tatooine with farmer Luke before he got ...

What if the tools you rely on to streamline your workflows could either supercharge your productivity or leave you stuck in a maze of limitations? That’s the critical decision many face when choosing ...

When In-N-Out Burger opened in Ridgefield last month, it wasn’t just the fast-food chain’s first Washington state location. It was the first in the greater Portland area — assuming you don’t mind the ...

Ice Cube is on his "Truth to Power: 4 Decades of Attitude Tour" and has released a new album, "Man Up." He believes speaking your truth gives you power and has maintained relevance by being his ...

The U.S. Department of Education announced a partnership Wednesday with more than 40 conservative organizations to create programming around civics aimed at the celebration of the 250th anniversary of ...

Vertex Pharmaceuticals is offering Enlaza Therapeutics more than $2 billion in biobucks through a multitarget drug discovery deal aiming to create new T-cell engagers and small-format drug conjugates.

In a lab nestled within Singapore’s innovation district, predictive models are being fine-tuned to help cities around the world make smarter decisions – from managing energy consumption to optimizing ...